This is a specific type of mast cell activation disorder. It means mast cells release their chemicals without growing too many of them. This can lead to symptoms like hives, stomach pain, and breathing difficulties.
Every report comes from a Lived member, sent anonymously.
Have you tried Zyrtec (Cetirizine) for MCAS (Mast Cell Activation Syndrome)?
Mast cell activation syndrome (MCAS) is a condition in which mast cells, immune cells found in the skin, gut, airways and around blood vessels, release their chemical signals too readily and all at once. Those signals, including histamine, are the same ones that drive an allergic reaction. The result is sudden, repeated episodes that look like a severe allergic reaction, often without an obvious allergen, and that affect at least two parts of the body at the same time. A typical episode starts abruptly with itching, flushing, hives or swelling, and is often joined by stomach cramps, diarrhea or vomiting, lightheadedness or fainting from low blood pressure, or wheezing and nasal congestion. Episodes usually settle within several hours. Many meet the definition of anaphylaxis, the most serious form of allergic reaction, and unexplained anaphylaxis is the classic presentation. The term MCAS is used in two very different ways. International expert criteria reserve it for clearly defined episodes like these, confirmed by laboratory evidence. A separate, much broader set of criteria applies the label to long-lasting symptoms such as fatigue, brain fog, headaches or bloating. Specialists have criticized that broader use because these chronic symptoms have not been shown to come from mast cells, and links with postural orthostatic tachycardia syndrome (POTS), hypermobile Ehlers-Danlos syndrome and long COVID have not been demonstrated in people who meet the stricter criteria.
Specialists sort MCAS by what lies behind the overactive mast cells. In primary (clonal) MCAS, a group of mast cells carries a genetic change, usually one called KIT D816V, that makes them easier to set off; some of these people have mastocytosis, a disorder in which abnormal mast cells build up in the body. In secondary MCAS, an underlying condition such as an IgE-mediated allergy (the antibody-driven type behind food, drug and insect-sting allergies) is driving the episodes. When neither is found, the diagnosis is idiopathic MCAS, meaning the cause is unknown, and the search for one continues. Some people have more than one of these at once, and they tend to have the most severe reactions. An inherited trait called hereditary alpha-tryptasemia, present in roughly 6% of people, raises the level of tryptase (a mast cell enzyme) in the blood. It does not cause MCAS by itself, but it is more common in people with unexplained anaphylaxis and may make reactions more intense. Triggers are separate from causes. Episodes can be set off by exercise, heat, emotional stress, alcohol or anti-inflammatory painkillers such as ibuprofen and aspirin, and some arrive with no trigger at all, even waking a person at night. When episodes regularly follow meals within an hour or two, a hidden food allergy, sometimes one that only causes a reaction when combined with exercise, alcohol or a painkiller, needs to be ruled out.
No single test diagnoses MCAS. A diagnosis under the international consensus criteria requires three things: repeated episodes typical of mast cell activation involving at least two organ systems, laboratory proof that mast cells released their contents during an episode, and improvement with medicines that block or calm mast cells. The preferred laboratory evidence is a rise in blood tryptase measured against the person's own baseline. A sample is drawn within about 4 hours of an episode starting and compared with a level taken on a symptom-free day. The rise counts when the episode value reaches at least 120% of baseline plus 2 ng/mL. For someone whose usual level is 5, that means 8 or higher. Because tryptase falls quickly, a test taken late can miss an episode, so many specialists give patients a lab order to keep with their epinephrine. Urine tests for breakdown products of histamine, prostaglandins and leukotrienes, collected a few hours after an episode and compared with baseline, are an alternative, though they are less specific. A high tryptase level on an ordinary day is not evidence of MCAS. It can reflect hereditary alpha-tryptasemia, kidney disease or a clonal mast cell disorder, and further testing may include a genetic test for the tryptase trait. The evaluation also looks for explanations that change treatment. An allergist will check for food allergy, reactions to anti-inflammatory painkillers and other secondary causes. A sensitive blood test for the KIT D816V change is recommended for people with unexplained anaphylaxis, and when a scoring system suggests clonal disease is likely, a bone marrow biopsy may follow. Because many conditions cause flushing, stomach symptoms or fatigue, most people referred for suspected MCAS turn out to have something else.
Treatment has two parts: stopping a serious episode quickly and making episodes less frequent. The evidence for most options is limited and comes mainly from expert experience, small studies and research in related conditions such as mastocytosis and chronic hives, so finding the right combination often takes trial and adjustment. Epinephrine, given with an auto-injector such as EpiPen, is the main treatment for a serious episode, especially anaphylaxis. It acts quickly, which is why it comes first in a severe reaction. Antihistamine pills can ease a milder episode but act slowly and cannot replace epinephrine in a severe one. People with MCAS are usually advised to carry two injectors. Prevention usually starts with a daily non-drowsy antihistamine that blocks the H1 histamine receptor, such as cetirizine (Zyrtec) or fexofenadine (Allegra), sometimes at up to four times the usual dose under a specialist's direction. These mainly help itching, hives and swelling. If symptoms continue, options are added according to which symptoms persist: an H2 blocker such as famotidine (Pepcid) for stomach symptoms; montelukast (Singulair), which blocks leukotrienes, another mast cell chemical; oral cromolyn, a liquid taken several times a day before meals that may calm gut symptoms and needs about a month to judge; and, in selected cases, aspirin to reduce prostaglandin release, which is only started after confirming the person tolerates it. Montelukast carries an FDA boxed warning about mood and behavior changes, which is worth weighing with the prescriber. For severe episodes that keep happening despite these steps, a specialist may consider omalizumab (Xolair), an injected antibody that blocks IgE, used off-label for MCAS; observational reports suggest fewer episodes for many people, though small trials have not proven it. Short courses of steroid pills such as prednisone are kept for severe, hard-to-control cases because of their side effects. When a clonal mast cell disorder is found, treatment of that disorder, and sometimes venom allergy shots for people at risk from insect stings, becomes part of the plan.
The course of MCAS varies, but the outlook is often better than people fear. Many patients reach good control on antihistamines alone, and some go into remission, allowing medicines to be gradually reduced under a specialist's guidance. Others need several medicines to keep episodes infrequent and milder. Episodes in the same person tend to look similar to one another, which helps people recognize them and act early. Daily life usually involves knowing personal triggers, carrying epinephrine, and having a written plan for what to do during an episode. Keeping a simple diary of episodes, what preceded them and how they responded helps the care team adjust treatment. Fatigue for up to a day after a major episode is common. Living with unpredictable reactions can be stressful, and anxiety is a normal response. Anxiety can also intensify episodes or produce symptoms that feel like them, so talking about it with the care team is part of good management, not a sign that symptoms are imagined. People found to have a clonal mast cell disorder need ongoing monitoring of blood counts and bone health in addition to their MCAS care.
See an allergist or immunologist if you have repeated, sudden episodes involving two or more body systems, such as flushing or hives together with stomach cramps, lightheadedness or breathing symptoms, or if you have had anaphylaxis without a clear cause. Contact your care team if episodes are becoming more frequent or severe despite treatment, or if a medicine causes troubling side effects, including mood or behavior changes on montelukast. Trouble breathing, throat tightness, fainting or a sense of collapse, or widespread hives with vomiting are signs of anaphylaxis. Use your epinephrine auto-injector right away and call 911, even if symptoms start to improve. If you can, ask for a tryptase blood test within 4 hours of the episode starting.
Last reviewed • Oct 2026
Educational content, not medical advice.
Does anyone have an MCAS diagnosis, and experience many MCAS symptoms without always reflecting what a practitioner would look to see in alignment cardiovascularly? My PT recently told me that although I was referred to PT for MCAS by my Dr., showed some signs when we initially met, I just wasn’t showing the cardiovascular signs they’d normally expect to see from someone who has the condition. Not sure what to do with this….
I tried Progesterone (yam root), Vitex (chaste berry), Calcium D-Glucarate, and Lupron. Each of these worsened my MCAS and did not relieve my perimenopause symptoms. The worst was the progesterone- I had a severe allergic reaction to it and spent 10 days on the verge of anaphylaxis until it left my system. All my MCAS symptoms worsen at ovulation and certain other parts of my cycle. I have found no relief.